Q: What is Mepolizumab used for?

Mepolizumab is used to treat the following conditions: Severe eosinophilic asthma Eosinophilic granulomatosis with polyangiitis Hypereosinophilic syndrome

Q: What are the brand names for Mepolizumab?

Mepolizumab is sold under the brand name Nucala .

Q: What are the active ingredients in Mepolizumab?

The active ingredient in Mepolizumab is mepolizumab .

Q: What are the side effects of Mepolizumab?

Common side effects of Mepolizumab may include: headache injection site reactions back pain Always consult with a healthcare professional about potential side effects.

Q: What drug class is Mepolizumab?

Mepolizumab belongs to the anti-IL-5 monoclonal antibody drug class.

Q: What is the dosage of Mepolizumab and how do I take it?

Administration Method Mepolizumab is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is typically administered once every four weeks. Initial doses are often given by a healthcare provider in a medical setting. Depending on the specific condition being treated and the patient's age, a doctor may determine that the medication can be self-administered at home using a prefilled syringe or autoinjector. Patients or caregivers must receive proper training from a healthcare professional before attempting to give the injection at home. Injection Sites The injection is usually given in the thigh, abdomen, or upper arm. If a caregiver is administering the dose, the upper arm is an option; however, for self-injection, the thigh or abdomen are preferred. It is important to rotate the injection site with each dose. Preparation and Handling The medication is stored in the refrigerator. Before use, it should be removed from the refrigerator and allowed to reach room temperature naturally. Do not use external heat sources, such as a microwave or hot water, to warm the medication. Do not shake the syringe or autoinjector. Missed Dose If a dose is missed, it should be administered as soon as it is remembered. The subsequent dose should then be taken on the regular scheduled day. If it is almost time for the next scheduled dose, contact a healthcare provider for guidance on how to proceed. Do not administer two doses at the same time to make up for a missed one.

Q: Is Mepolizumab safe during pregnancy and breastfeeding?

Pregnancy The safety of mepolizumab during pregnancy has not been fully established in humans. While animal studies have not indicated a high risk of birth defects or pregnancy loss, there is insufficient data from human studies to confirm its safety. Because mepolizumab is a monoclonal antibody, it is likely to cross the placenta and reach the fetus, particularly during the second and third trimesters. If you are pregnant or planning to become pregnant, your doctor will help you decide if the benefits of treating your condition outweigh the potential risks to the fetus. There is a pregnancy exposure registry that monitors outcomes for individuals who take this medication while pregnant. Breastfeeding It is not known if mepolizumab passes into human breast milk or if it has any effect on a nursing infant or milk production. Because many medications can be present in breast milk, it is important to talk to a healthcare provider about the risks and benefits of breastfeeding while using this medication.

Question 1

What is Mepolizumab?

Accepted Answer

Mepolizumab is a laboratory-made protein known as a monoclonal antibody. It works by targeting and blocking interleukin-5, a specific signaling protein that regulates the production and survival of eosinophils.

By interfering with this process, the medication helps lower the number of these white blood cells in the blood and tissues. This reduction in eosinophils helps manage inflammatory conditions where these cells play a significant role.

Question 2

What is Mepolizumab used for?

Accepted Answer

Mepolizumab is used to treat the following conditions:

Severe eosinophilic asthma
Eosinophilic granulomatosis with polyangiitis
Hypereosinophilic syndrome

Question 3

How does Mepolizumab work?

Accepted Answer

Mepolizumab is a type of medication known as an interleukin-5 (IL-5) antagonist. It is a monoclonal antibody specifically designed to target and bind to IL-5, which is a signaling protein in the immune system responsible for the growth, activation, and survival of eosinophils.

Eosinophils are white blood cells that normally help the body fight infections. However, in people with certain conditions, the body produces an excessive amount of these cells. When eosinophil levels are too high, they can cause significant inflammation and swelling in the lungs, nasal passages, and other tissues, leading to symptoms like breathing difficulties or flare-ups.

Mepolizumab works by attaching itself to the IL-5 protein. This action prevents IL-5 from binding to its receptors on the surface of eosinophils. By interrupting this signaling process, the medication helps to:

Reduce cell production: It limits the number of new eosinophils produced by the bone marrow.
Lower cell survival: It decreases the lifespan of eosinophils already circulating in the body.
Decrease inflammation: By lowering the concentration of eosinophils in the blood and tissues, the drug reduces the underlying inflammation that causes symptoms.

Question 4

What are the brand names for Mepolizumab?

Accepted Answer

Mepolizumab is sold under the brand name Nucala.

Question 5

What are the active ingredients in Mepolizumab?

Accepted Answer

The active ingredient in Mepolizumab is mepolizumab.

Question 6

What are the side effects of Mepolizumab?

Accepted Answer

Common side effects of Mepolizumab may include:

headache
injection site reactions
back pain

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Mepolizumab?

Accepted Answer

Mepolizumab belongs to the anti-IL-5 monoclonal antibody drug class.

Question 8

What is the dosage of Mepolizumab and how do I take it?

Accepted Answer

Administration Method

Mepolizumab is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is typically administered once every four weeks.

Initial doses are often given by a healthcare provider in a medical setting. Depending on the specific condition being treated and the patient's age, a doctor may determine that the medication can be self-administered at home using a prefilled syringe or autoinjector. Patients or caregivers must receive proper training from a healthcare professional before attempting to give the injection at home.

Injection Sites

The injection is usually given in the thigh, abdomen, or upper arm.
If a caregiver is administering the dose, the upper arm is an option; however, for self-injection, the thigh or abdomen are preferred.
It is important to rotate the injection site with each dose.

Preparation and Handling

The medication is stored in the refrigerator. Before use, it should be removed from the refrigerator and allowed to reach room temperature naturally. Do not use external heat sources, such as a microwave or hot water, to warm the medication. Do not shake the syringe or autoinjector.

Missed Dose

If a dose is missed, it should be administered as soon as it is remembered. The subsequent dose should then be taken on the regular scheduled day. If it is almost time for the next scheduled dose, contact a healthcare provider for guidance on how to proceed. Do not administer two doses at the same time to make up for a missed one.

Question 9

Is Mepolizumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

The safety of mepolizumab during pregnancy has not been fully established in humans. While animal studies have not indicated a high risk of birth defects or pregnancy loss, there is insufficient data from human studies to confirm its safety. Because mepolizumab is a monoclonal antibody, it is likely to cross the placenta and reach the fetus, particularly during the second and third trimesters.

If you are pregnant or planning to become pregnant, your doctor will help you decide if the benefits of treating your condition outweigh the potential risks to the fetus. There is a pregnancy exposure registry that monitors outcomes for individuals who take this medication while pregnant.

Breastfeeding

It is not known if mepolizumab passes into human breast milk or if it has any effect on a nursing infant or milk production. Because many medications can be present in breast milk, it is important to talk to a healthcare provider about the risks and benefits of breastfeeding while using this medication.

Question 10

What forms and strengths does Mepolizumab come in?

Accepted Answer

Mepolizumab is provided as a solution for injection under the skin. It is available in the following delivery systems:

Prefilled Autoinjector: A single-dose, disposable device for use by patients or caregivers after receiving proper training.
Prefilled Syringe: A single-dose syringe with a needle, which may be used by patients, caregivers, or healthcare providers.
Single-dose Vial (Powder): A vial containing a powder that a healthcare professional must mix with sterile water before administration.
Single-dose Vial (Liquid): A vial containing a liquid solution intended for administration by a healthcare professional.

Question 11

What is the FDA approval status of Mepolizumab?

Accepted Answer

FDA Approval and Indications

Mepolizumab was first approved by the U.S. Food and Drug Administration (FDA) in 2015. It is a humanized interleukin-5 antagonist monoclonal antibody indicated for the following uses:

Severe Eosinophilic Asthma: As an add-on maintenance treatment for patients aged 6 years and older whose asthma is not adequately controlled by their current medications.
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): As an add-on maintenance treatment for adult patients who have not responded adequately to nasal corticosteroids.
Eosinophilic Granulomatosis with Polyangiitis (EGPA): For the treatment of adult patients with this rare autoimmune condition.
Hypereosinophilic Syndrome (HES): For the treatment of adults and pediatric patients aged 12 years and older who have had the condition for at least six months without an identifiable non-blood-related cause.

Regulatory Safety Information

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for mepolizumab. However, the regulatory labeling includes several important safety warnings:

Hypersensitivity Reactions: Serious allergic reactions, including anaphylaxis, have been reported. These reactions can occur within hours or sometimes days after the injection.
Herpes Zoster Infections: Shingles infections have occurred in patients receiving the drug. Healthcare providers may recommend vaccination before starting treatment.
Corticosteroid Reduction: The FDA advises that patients should not stop or reduce their systemic or inhaled corticosteroids abruptly when starting mepolizumab. Any changes to steroid dosages must be done gradually under medical supervision.

Mepolizumab is also recognized in the FDA table of pharmacogenomic biomarkers for its specific application in patients with an eosinophilic phenotype.

Question 12

What should I know about Mepolizumab and cost?

Accepted Answer

Factors Influencing Cost

Several factors can affect the total price of mepolizumab treatment:

Insurance Coverage: Your out-of-pocket costs will depend on your specific health insurance plan, including your deductible, copayment, and coinsurance levels.
Formulation: Mepolizumab is available as a prefilled autoinjector, a prefilled syringe, or a vial for reconstitution. The cost may differ depending on which form your doctor prescribes.
Administration Site: If the medication is administered by a healthcare professional in a clinic or hospital setting, there may be additional fees for the office visit and the injection procedure.

Generic Availability

Mepolizumab is a biologic medication currently available only under the brand name Nucala. There is no generic or biosimilar version available at this time, which generally means the cost remains higher than for medications with generic alternatives.

Financial Assistance

The manufacturer may offer patient assistance programs or copay cards to help eligible individuals with commercial insurance reduce their out-of-pocket expenses. Patients without insurance or those with government-funded insurance (such as Medicare or Medicaid) may have different eligibility requirements for financial support programs.

Mepolizumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Mepolizumab

Hospitals.net Disclosure